Tvardi Therapeutics, Inc. (FRA:69C)

Tvardi Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jan 29, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Debt / Equity Ratio	0.01	-5.43	0.02	0.01
Quick Ratio	3.30	3.05	6.99	10.23
Current Ratio	3.48	3.06	7.97	10.31
Return on Equity (ROE)	-135.64%	-329.99%	-54.30%	-
Return on Assets (ROA)	-72.68%	-56.48%	-32.36%	-
Return on Capital Employed (ROCE)	-107.10%	-113.20%	-78.70%	-51.90%
Buyback Yield / Dilution	-170.52%	-0.31%	-0.09%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.